SBIR/STTR Research Award

High through-put chemical synthesis of proteins

Award identifier bf7263bcd8192f1e3675fb609f7d5da706b91a32d3f0578affbc89390611bf57Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$167,164

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
PROSYNTH, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant):The objectives of the Protein Structure Initiative is to determine the structure of 10,000 proteins from the Human Genome Project. Chemical synthesis is a useful way to produce these proteins particularly when they cannot be efficiently cloned. ProSynth, Inc. has developed technology that allows the synthesis of pure, protected fragments at relatively low cost. In the Excluded Protecting Group method a growing peptide is attached to a steroid "handle" and purified by gel permeation chromatography after addition of each amino acid residue. Orthogonally protected peptides synthesized this way can then be coupled either in solution or on the solid phase. ProSynth, Inc. will demonstrate its technology by the synthesis and coupling of two peptide fragments that make up the 26-residue protein melittin. This peptide will be characterized for purity and tested for biological activity. In a second experiment the EPG technique will be used to prepare the protein ubiquitin. The six fragments ranging from six to 22 amino acids will be synthesized and to generate the desired product. The focus of this synthesis will be to determine the reaction order for various couplings in order to predict when a desired degree of coupling has been reached. PROPOSED COMMERCIAL APPLICATION: This technology will allow proteins to be designed and produced. This should allow for protein drugs to be improved yielding superior protein drugs for clinical application.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.